Morgan Stanley Maintains Equal-Weight on Clorox, Lowers Price Target to $87
Morgan Stanley analyst Dara Mohsenian maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $97 to $87.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga